Johanna Sistonen
Helsinki, Finland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Value of Pharmacogenetic Testing Assessed with Real-World Drug Utilization and Genotype Data.
Journal: Clinical pharmacology and therapeutics
Published: June 08, 2024
Solanidine is a sensitive and specific dietary biomarker for CYP2D6 activity.
Journal: Human genomics
Published: November 02, 2023
Inhibition of efflux transporters by poly ADP-ribose polymerase inhibitors.
Journal: Basic & clinical pharmacology & toxicology
Published: May 05, 2023
Correction to: Diagnostic utility of next-generation sequencing-based panel testing in 543 patients with suspected skeletal dysplasia.
Journal: Orphanet journal of rare diseases
Published: February 18, 2022
Prevalence of RPGR-Mediated Retinal Dystrophy in an Unselected Cohort of Over 5000 Patients.
Journal: Translational vision science & technology
Published: January 05, 2022
GRINL1A Complex Transcription Unit Containing GCOM1, MYZAP, and POLR2M Genes Associates with Fully Penetrant Recessive Dilated Cardiomyopathy.
Journal: Frontiers in genetics
Published: September 30, 2021
Diagnostic utility of next-generation sequencing-based panel testing in 543 patients with suspected skeletal dysplasia.
Journal: Orphanet journal of rare diseases
Published: July 16, 2021
Biallelic loss-of-function in NRAP is a cause of recessive dilated cardiomyopathy.
Journal: PloS one
Published: June 18, 2020
Diagnostic yield of genetic testing in a heterogeneous cohort of 1376 HCM patients.
Journal: BMC cardiovascular disorders
Published: May 24, 2020
Showing 1-9 of 9
Last Updated: 09/26/2026